Hello Tengku Ahmad Damitri Al-AstaniWe haven't heard from you in a while, so please get in touch to know your interest in the 3rd International Conference on Cancer Science and Therapy set to occur in Bangkok, Thailand from May 06-07, 2024.We are happy to welcome you and your student to join our conference as Speakers.Also, as per your request, we are glad to extend the scholarship benefits to your student to join our event.To proceed further, kindly submit your abstract of presentation at https://www.cancer.scientexconference.com/submitabstract Once your abstract gets screened through the review process successfully, you will be prompted towards the registration process to confirm your participation slot in the conference.Once you both confirm your participation, you will be provided with the official letter of invitation.We appreciate your soonest response.

Dear Prof/Assoc Prof/Dr, The National Cancer Society of Malaysia (NCSM) and Sunway University are collaborating to organise the National Cancer Congress Malaysia (NCCM) 2024. We cordially invite you, your collaborators and your students to submit abstracts for rapid-fire oral presentation sessions held throughout the event. A total of 150 high-quality abstracts will be accepted. You can access the abstract portal here: https://nccm.cancer.org.my/abstract/ The event details are as follows: Date:       21st - 23rd June 2024Time:      8.00 am - 4.30pmPlace:      Sunway University, Jalan Universiti, Bandar Sunway, SelangorTheme:     Bridging Gaps, Building Hope, Empowering Lives 2.     The National Cancer Congress Malaysia (NCCM) 2024 is set to be a pioneering event, providing a distinctive platform for participants to engage, derive inspiration, and remain abreast of the latest advancements in cancer control. The event seeks to bolster the influence and effectiveness of the cancer community through its comprehensive scientific programme covering every aspect of cancer, ranging from prevention, screening and diagnosis, treatment, survivorship, advocacy and policy. 3.     Under the theme "Bridging gaps, building hopes, empowering lives," NCCM 2024 strives to unite stakeholders in cancer care including oncologists, physicians, researchers, allied health professionals, and industry representatives to exchange insights and ideas among participants working in the field of cancer control. The three-day congress will feature scientific sessions encompassing a wide range of topics related to cancer, including advancements in cancer research, emerging modalities and discussion on enhancing cancer care. NCCM 2024 is a HRDF-claimable event. We are also in the process of obtaining CPD eligibility. For further details, please visit: www.nccm.cancer.org.my. 4.         Selected abstracts will be given an opportunity to be presented in the form of 5-minute rapid-fire oral presentations held throughout the 3 days of NCCM 2024. A typical rapid-fire oral presentation is approximately 5-minutes in length, with 3 minutes for study presentation and another 2 minutes of Q&A. A maximum of 5 slides are allowed for the oral presentation. 5.         Benefits of presenting at NCCM 2024:NCSM Partners get a special early-bird registration rate of RM600 per pax (non-student) or RM300 per pax (student). For more information, please refer to the attached document on Partnering with NCSM. If you are interested in partnering with NCSM, please fill out the attached Partnering form in send it back to us.All accepted abstracts will be collated into a citable, ISBN-registered conference proceeding.This conference is open to 50 student participants, giving a chance to up-and-coming scientists to present the next generation of cancer research at an international event.The best abstracts will be given Merit Awards. A total of 16 Awards will be given to non-student submissions, while a total of 4 Awards will be given to student submissions. Winners of the Merit Award will have their entry fee reimbursed by NCCM.6.         Details of abstract submission are as follows:Abstract submission opens: 1st April 2024Abstract submission deadline: 30th April 2024Early bid deadline: 15th May 2024Abstract withdrawal deadline: 21st May 20247.    More information is available in the Call for Abstracts document attached with this email. Alternatively, feel free to contact Dr Kavinash Loganathan at [email protected] or call +6012-6546843 or Dr Janice Hew at [email protected] or call +6019-487 7682. Thank you for considering our invitation. We look forward to hearing you and/or your students present at NCCM 2024. Best Regards,

We are happy to welcome you and your student to join our conference as Speakers.Also, as per your request, we are glad to extend the scholarship benefits to your student to join our event.To proceed further, kindly submit your abstract of presentation at https://www.cancer.scientexconference.com/submitabstract Once your abstract gets screened through the review process successfully, you will be prompted towards the registration process to confirm your participation slot in the conference.Once you both confirm your participation, you will be provided with the official letter of invitation.You may share your WhatsApp contact number for receiving instant conference updates and for better communication.Looking forward to hearing from you soon.

Tue 5/28/2024 7:59 PMMy name is Saeeda Akbar, and I am keen on participating in research within Breast Cancer.I am currently enrolled  at the University of Lincoln .I have published three articles in HEC recognized journal.Having reviewed your faculty profile and ad about breast cancer. I am eager to contribute to breast cancer area of study as it aligns with my long-term goals.Could we schedule a meeting to discuss and my potential involvement in your research? I am available on 2nd June . I appreciate your consideration and look forward to hearing from you.Respectfully,

Dear Dr. Tengku Din,Good day.I'm Ensley, an assistant editor of Exploration of Targeted Anti-tumor Therapy. Glad to contact you.In light of your expertise, I'm writing to sincerely invite you to review a manuscript ETAT-D-24-00025 entitled “Evaluation of HER2 Immunohistochemistry Expression in Non-Standard Solid Tumors from a Single-Institution Prospective Cohort”for our journal.The default review time is 14 days and the manuscript information is below the email for your reference.Could you please let me know whether you would accept the invitation to review this manuscript at your earliest convenience? If you accept the invitation, please reply to me and I will send you the full-text review link so that you could process the review. If you are unavailable this time, we would appreciate you recommending another expert.Thank you for your consideration.

It’s a great idea to work on ferulic acid as anti- breast cancer, I am available to work with you in any research about breast cancer . I’m really so interested to be your student.